Bioactive Compounds for the Mammary Gland Cancer
A special issue of Applied Sciences (ISSN 2076-3417). This special issue belongs to the section "Applied Biosciences and Bioengineering".
Deadline for manuscript submissions: closed (20 July 2022) | Viewed by 478
Special Issue Editor
Interests: cancer cell line; tumors; cancer; cancer cells; xenograft studies; breast cancer; cancer biology; cancer biomarkers; cell culture; cancer diagnostics; apoptosis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue will consist of comprehensive reviews and original research articles featuring the impact of bioactive compounds on mammary gland cancer development with particular emphasis on the inflammatory process. Natural products or extracts, especially vitamin D compounds (vitamin D metabolites, natural and synthetic analogues), are known to exhibit therapeutic effects against breast cancer, mainly by lowering the expression of estrogen receptors and aromatase activity.
Subject areas include but are not limited to the development of the inflammatory process accompanying breast cancer, the molecular mechanisms of the actions of various bioactive compounds inhibiting breast cancer proliferation and progression, and new strategies to support breast cancer therapy. In addition, research on vitamin D and its analogs on breast cancer, the effect of vitamin D levels in the blood, vitamin D supplementation, new vitamin D analogues and anti-inflammatory effects is particularly welcomed.
We welcome original experimental research, review articles, and commentary articles that lead to a better understanding of the biological mechanisms driving the origins and progression of cancer. Authors who are experts in these fields of study are invited to submit their contributions to this Special Issue.
Dr. Beata Filip-Psurska
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Applied Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- mammary gland cancer
- bioactive compounds
- natural products
- vitamin D analogs
- cancer-associated inflammation
- breast cancer therapy
